BIFIDOVID
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Apr 2022)
What this means for you
This application is over — abandoned 11 Apr 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90215065
- Mark type
- Stylized text
- Filed
- 27 Sept 2020
- Published for opposition
- 13 Jul 2021
- Abandoned
- 11 Apr 2022
Goods and services
- Class 005 — Pharmaceuticals: Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplements; Dietary supplements for human beings and animals; Dietary supplements for human consumption; Dietary supplements for humans and animals; Dietary supplements in the nature of weight loss powders; Dietary supplements with a cosmetic effect; Dietary and nutritional supplements; Dietary and nutritional supplements containing bifidobacterium; Dietary and nutritional supplements used for weight loss; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Chlorella dietary supplements; Ketogenic dietary and nutritional supplements; Natural dietary supplements; Nutraceuticals for use as a dietary supplement; Zinc dietary supplements
Owner
- Christine Bishara medical practice Pllc, ny, NY, US
- Christine Bishara medical practice Pllc, ny, NY, US
Prosecution history
- 11 Apr 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Apr 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Sept 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jul 2021 — PUBLISHED FOR OPPOSITION
- 23 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jun 2021 — ASSIGNED TO LIE
- 04 Mar 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Feb 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Feb 2021 — NON-FINAL ACTION E-MAILED
- 23 Feb 2021 — NON-FINAL ACTION WRITTEN
- 17 Feb 2021 — ASSIGNED TO EXAMINER